Clough, Bret H.
Ylostalo, Joni
Browder, Elizabeth
McNeill, Eoin P.
Bartosh, Thomas J.
Rawls, H. Ralph
Nakamoto, Tetsuo
Gregory, Carl A.
Funding for this research was provided by:
National Institutes of Health (2P40RR017447-07)
Theocorp Holding Co
Institute for Regenerative Medicine Program Funds
Article History
Received: 30 September 2016
Accepted: 25 November 2016
First Online: 2 December 2016
Compliance with Ethical Standards
:
: TN is co-founder of Theocorp Holding Co. CAG and HRR are members of the Scientific Advisory Board of Theocorp Holding Co. BHC, JY, EB, EPM and TJB state no competing interests.
: Animal studies were performed in accordance with an ethical animal use protocol approved by the Texas A&M Institutional Animal Care and Use Committee. Human mesenchymal stem cells were acquired from the Texas A&M Health Science Center Institute for Regenerative Medicine in accordance with a Baylor Scott and White Hospital and Texas A&M Health Science Center Institutional Review Board approved protocol for ethical acquisition of human tissue samples.